Xenco Medical

Xenco Medical Unveils the TrabeculeX Continuum, a Breakthrough Convergence of Digital Health and Biomaterials, at CES 2024 in Las Vegas, the World’s Largest Technology Conference

Retrieved on: 
Tuesday, January 16, 2024
Health, Medical Devices, Surgery, Health Technology, Other Health, General Health, Biotechnology, Digital health, Patient, Regenerative medicine, Architecture, Multimedia, Rehabilitation, Consumer Electronics Show, Electronics, Xenco Medical, FDA, Surgeon, Medical device

On January 11th, trailblazing medical technology company Xenco Medical unveiled its convergent technology bridging Digital Health and Biomaterials by showcasing its TrabeculeX Continuum™ at the 2024 Consumer Electronics Show in Las Vegas, Nevada.

Key Points: 
  • On January 11th, trailblazing medical technology company Xenco Medical unveiled its convergent technology bridging Digital Health and Biomaterials by showcasing its TrabeculeX Continuum™ at the 2024 Consumer Electronics Show in Las Vegas, Nevada.
  • Comprising the FDA-cleared TrabeculeX Bioactive Matrix™ and the TrabeculeX Recovery App™, the TrabeculeX Continuum is the first technology-enabled bridge between orthobiologics and digital health, unifying a patient’s biomaterial implantation and postoperative journey.
  • View the full release here: https://www.businesswire.com/news/home/20240116950427/en/
    On January 11th, trailblazing medical technology company Xenco Medical unveiled its convergent technology bridging Digital Health and Biomaterials by showcasing its TrabeculeX Continuum™ at the 2024 Consumer Electronics Show in Las Vegas, Nevada.
  • Comprising the TrabeculeX Bioactive Matrix™ and the TrabeculeX Recovery App™, the TrabeculeX Continuum is the first technology-enabled bridge between orthobiologics and digital health, unifying a patient’s biomaterial implantation and postoperative journey.

4WEB Medical Receives 510k Clearance to Market New Integrated Cervical Plate

Retrieved on: 
Wednesday, September 27, 2023
Momentum, Medicine, Most, Research and development, Development, CSTS, Growth, Xenco Medical, Lordosis, Birth control, Fine chemical, DALLAS, Q3, Research

DALLAS, Sept. 27, 2023 /PRNewswire/ -- 4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology™, announced that it has received 510K clearance to market the newest additions to the company's implant portfolio, the Cervical Spine Truss System (CSTS) Integrated Plating Solution and two cervical interbody line extensions which include implants with 12 degrees of lordosis and an option for a large footprint (16mm x19mm).

Key Points: 
  • Jonathan Hires, Director of Research and Development commented, "The CSTS Integrated Plating Solution provides an additional stand-alone treatment option for 4WEB's surgeon customers.
  • With two product launches in Q3 and regulatory clearance for the integrated plate, we have built significant momentum towards completing the company's comprehensive cervical portfolio by the end of the year."
  • The CSTS Integrated Plating Solution clearance follows several recent milestones including the launch of a non-integrated cervical plating solution and a second-generation cervical interbody fusion device which came to market in Q3.
  • With this portfolio expansion and continued product development, 4WEB has established itself as a leader in the cervical interbody fusion market.

Xenco Medical Named One of the World’s Most Innovative Companies by Fast Company Magazine

Retrieved on: 
Tuesday, March 7, 2023
Biotechnology, Technology, Health, Health Technology, Other Science, Medical Devices, Software, Surgery, Internet, Mobile, Wireless, Science, Healthcare Facilities Accreditation Program, Xenco Medical, Surgeon, Multimedia, Sterilization, Multilevel, Medical device, Cryptocurrency

Pioneering surgical technology company Xenco Medical has been named as one of the World’s Most Innovative Companies by Fast Company Magazine in its distinguished 2023 list.

Key Points: 
  • Pioneering surgical technology company Xenco Medical has been named as one of the World’s Most Innovative Companies by Fast Company Magazine in its distinguished 2023 list.
  • Chosen from renowned companies across the globe, selection to the list is widely recognized as the preeminent honor a company can receive for its innovations.
  • According to Fast Company Magazine, “This year’s list highlights the businesses at the forefront of their respective industries, paving the way for the innovations of tomorrow.
  • View the full release here: https://www.businesswire.com/news/home/20230307005033/en/
    Xenco Medical has been named one of the World’s Most Innovative Companies by Fast Company Magazine in its prestigious 2023 list.

The World Economic Forum Names Xenco Medical the Winner of the 2022 New Champions Award for Excellence in Sustainable Growth

Retrieved on: 
Wednesday, December 7, 2022
Technology, Surgery, Medical Devices, Professional Services, Hospitals, Science, Medical Supplies, Biotechnology, Health, Packaging, Engineering, Other Science, Chemicals, Plastics, Research, Manufacturing, Electronic Design Automation, Venture Capital, World Economic Forum, MRI, Xenco Medical, Science, CT, Surgeon, Multimedia, Pharmaceutical industry, Medical device, Development

The World Economic Forum, the worlds foremost international organization for public-private cooperation, has named U.S.-based medical technology company Xenco Medical the winner of its 2022 New Champions Award for Excellence in Sustainable Growth.

Key Points: 
  • The World Economic Forum, the worlds foremost international organization for public-private cooperation, has named U.S.-based medical technology company Xenco Medical the winner of its 2022 New Champions Award for Excellence in Sustainable Growth.
  • Xenco Medical Founder and CEO Jason Haider accepted the award from the World Economic Forum at an awards ceremony in Geneva, Switzerland, on December 2nd.
  • View the full release here: https://www.businesswire.com/news/home/20221207005014/en/
    The World Economic Forum has named Xenco Medical the winner of the 2022 New Champions Award for Excellence in Sustainable Growth.
  • Xenco Medical is an American medical technology company committed to disruptive innovation for the purposes of creating a safer surgical environment.

Xenco Medical Expands its Ambulatory Surgery Center Device Portfolio with FDA Clearance and Launch of its Multilevel CerviKit

Retrieved on: 
Tuesday, June 14, 2022
Research, Medical Devices, Surgery, Medical Supplies, Hospitals, Venture Capital, Professional Services, Biotechnology, Health, Science, Science, Multilevel, Sterilization, Medicine, Xenco Medical, Multimedia, FDA, Growth, Patient, Technology, COVID-19, Efficiency, Risk-based testing, ASC, Medical device

Optimized for the ambulatory surgery center setting, the Multilevel CerviKitbuilds on Xenco Medicals existing portfolio of disposable spinal implant and instrument platforms included in its ASC CerviKit and adds to its portfolio of single-use lumbar surgical devices.

Key Points: 
  • Optimized for the ambulatory surgery center setting, the Multilevel CerviKitbuilds on Xenco Medicals existing portfolio of disposable spinal implant and instrument platforms included in its ASC CerviKit and adds to its portfolio of single-use lumbar surgical devices.
  • Matched with a disposable delivery instrument and coupled with corresponding, single-use surgical instruments, the Multilevel CerviKit is engineered to complement Xenco Medicals existing portfolio of single-use spinal systems.
  • View the full release here: https://www.businesswire.com/news/home/20220614005007/en/
    Xenco Medical has expanded its ASC surgical device portfolio with the launch of its Multilevel CerviKit.
  • By expanding Xenco Medicals current ASC portfolio, the Multilevel CerviKit is designed to strengthen an ambulatory surgery centers ability to overcome sterilization bottlenecks while providing optimal care.

4WEB Medical Announces Record First Quarter Performance

Retrieved on: 
Thursday, May 26, 2022
Research and development, Vertebral column, Medicine, Multimedia, ACDF, View, Trauma, Review, FDA, Xenco Medical, Technology, Neoplasm, Growth, Development, Medical device, Renewable energy, Research

DALLAS, May 26, 2022 /PRNewswire/ -- 4WEB Medical, an orthopedic device company focused on developing innovative implants with an Advanced Structural Design utilizing its proprietary Truss Implant Technology™, announced today that the company achieved record revenue in Q1 2022, largely driven by sales of the company's stand alone devices for ALIF and ACDF procedures.

Key Points: 
  • "The company's spine business has now accomplished seven consecutive quarters of year over year growth with Q1 2022 being our highest revenue first quarter ever.
  • 4WEB currently has four FDA regulatory submissions under review with plans to launch multiple novel implant systems before the end of 2022.
  • 4WEB Medical, founded in 2008 in Dallas, TX, is an orthopedic implant company.
  • 4WEB Medical is actively developing truss implant designs for tumor, trauma, and patient-specific applications.

4WEB Medical Launches Hyperlordotic Lateral Implant Portfolio

Retrieved on: 
Thursday, February 24, 2022
Vertebral column, Neoplasm, Growth, Trauma, Marketing, ATP, Union of Sales and Marketing Professionals, Multimedia, Medicine, View, Technology, Patient, MD, Research, Spine, Xenco Medical, Medical device, Bookbinding

DALLAS, Feb. 24, 2022 /PRNewswire/ -- 4WEB Medical, an orthopedic device company focused on developing innovative implants with an Advanced Structural Design utilizing its proprietary Truss Implant Technology, announced today the company's launch of a comprehensive array of hyperlordotic lateral implants.

Key Points: 
  • DALLAS, Feb. 24, 2022 /PRNewswire/ -- 4WEB Medical, an orthopedic device company focused on developing innovative implants with an Advanced Structural Design utilizing its proprietary Truss Implant Technology, announced today the company's launch of a comprehensive array of hyperlordotic lateral implants.
  • "The new hyperlordotic implant offering, combined with an already comprehensive lateral portfolio, expands my treatment options for patients who need more extensive saggital balance correction."
  • The company's lateral access portfolio also includes procedural-based solutions developed for Direct Lateral, Anterior-to-Psoas (ATP), and Prone Lateral approaches to the lumbar spine.
  • The 4WEB Medical spine product portfolio includes the Cervical Spine Truss System, the Stand Alone Cervical Spine Truss System, the Anterior Spine Truss System, the Stand Alone Anterior Spine Truss System, the Posterior Spine Truss System, the Lateral Spine Truss System, and the Lumbar Spine Plating Solution.

4WEB Medical Exceeds Q2 Growth Projections

Retrieved on: 
Thursday, August 19, 2021
Medicine, Trauma, View, Research, Union of Sales and Marketing Professionals, Vertebral column, Multimedia, Marketing, Neoplasm, Technology, Xenco Medical, Medical device

DALLAS, Aug. 19, 2021 /PRNewswire/ --4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology, announced today that it exceeded growth projections for the second quarter of 2021.

Key Points: 
  • DALLAS, Aug. 19, 2021 /PRNewswire/ --4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology, announced today that it exceeded growth projections for the second quarter of 2021.
  • 4WEB revenue increased 95% in Q2 2021 over the prior year and 42% over Q2 2019.
  • More importantly, the company had sequential revenue growth of over 20% Q1 to Q2 2021.
  • "4WEB is in a high growth phase and very pleased with both its year-over-year and sequential quarter-over-quarter growth in 2021," said Geoff Bigos, Vice President of Spine Sales.

Xenco Medical Unveils HoloMedX, the First Glasses-Free Holographic Surgical Simulation Platform at the VR/AR Global Summit

Retrieved on: 
Thursday, June 10, 2021
Professional services, Health, Medical devices, Technology, Surgery, Other Technology, Venture capital, Emerging technologies, Prosthetics, 3D imaging, Xenco Medical, Medical technology, Implant, Science and technology, Holography, Technology

On June 4th, 2021, Xenco Medical unveiled HoloMedX, the first glasses-free holographic surgical simulation platform during a presentation by Xenco Medical Founder and CEO Jason Haider at the VR/AR Global Summit, the largest immersive tech event in the world.

Key Points: 
  • On June 4th, 2021, Xenco Medical unveiled HoloMedX, the first glasses-free holographic surgical simulation platform during a presentation by Xenco Medical Founder and CEO Jason Haider at the VR/AR Global Summit, the largest immersive tech event in the world.
  • The HoloMedX platform by Xenco Medical instantly adjusts the holographic scene to allow for glasses-free holographic viewing and interactivity by multiple users, simultaneously.
  • View the full release here: https://www.businesswire.com/news/home/20210610005258/en/
    Xenco Medical Founder and CEO Jason Haider demonstrating holographic spinal implant placement with HoloMedX.
  • (Photo: Business Wire)
    Featuring a library of holographic implants based on Xenco Medicals actual spinal implants, the platform enables users to manipulate holographic anatomy and the holographic implants with air controllers modeled after Xenco Medicals disposable surgical instruments, allowing for deeper engagement with the platform.

HT Medical Announces Name Change to Xēnix Medical as Part of Rebranding Initiative

Retrieved on: 
Wednesday, April 7, 2021
General Health, Medical devices, Technology, Other Manufacturing, Science, Surgery, Nanotechnology, Biotechnology, Other Technology, Manufacturing, Other Science, Health, Prosthetics, Medicine, Medical specialties, Biomedical engineering, Medical technology, Surgery, Orthopedic surgery, Implant, Xenco Medical, Breast implant

HT Medical, a surgical implant company focused on the development of novel science-based solutions for patients requiring spinal fusion surgery, today announced that it has changed its name to Xnix Medical as part of a rebranding initiative.

Key Points: 
  • HT Medical, a surgical implant company focused on the development of novel science-based solutions for patients requiring spinal fusion surgery, today announced that it has changed its name to Xnix Medical as part of a rebranding initiative.
  • Ryan Phillips, President of Xnix Medical, commented, We felt it was important for our corporate name to better represent the distinctive nature of our brand, culture, and fusion technologies.
  • Simply put, Xnix means challenging the status quo on every aspect of the way businesses operate in the orthopedic medical device industry.
  • Xnix Medical is a surgical implant company focused on the development of novel science-based solutions for patients requiring spinal fusion surgery.